Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer. [electronic resource] by
- Wali, Vikram B
- Langdon, Casey G
- Held, Matthew A
- Platt, James T
- Patwardhan, Gauri A
- Safonov, Anton
- Aktas, Bilge
- Pusztai, Lajos
- Stern, David F
- Hatzis, Christos
Producer: 20170724
In:
Cancer research vol. 77
Availability: No items available.
|
|
14.
|
The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitors. [electronic resource] by
- Langdon, Casey G
- Held, Matthew A
- Platt, James T
- Meeth, Katrina
- Iyidogan, Pinar
- Mamillapalli, Ramanaiah
- Koo, Andrew B
- Klein, Michael
- Liu, Zongzhi
- Bosenberg, Marcus W
- Stern, David F
Producer: 20160307
In:
Pigment cell & melanoma research vol. 28
Availability: No items available.
|
|
15.
|
SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells. [electronic resource] by
- Langdon, Casey G
- Wiedemann, Norbert
- Held, Matthew A
- Mamillapalli, Ramanaiah
- Iyidogan, Pinar
- Theodosakis, Nicholas
- Platt, James T
- Levy, Frederic
- Vuagniaux, Gregoire
- Wang, Shaomeng
- Bosenberg, Marcus W
- Stern, David F
Producer: 20160907
In:
Oncotarget vol. 6
Availability: No items available.
|
|
16.
|
Genotype-selective combination therapies for melanoma identified by high-throughput drug screening. [electronic resource] by
- Held, Matthew A
- Langdon, Casey G
- Platt, James T
- Graham-Steed, Tisheeka
- Liu, Zongzhi
- Chakraborty, Ashok
- Bacchiocchi, Antonella
- Koo, Andrew
- Haskins, Jonathan W
- Bosenberg, Marcus W
- Stern, David F
Producer: 20130620
In:
Cancer discovery vol. 3
Availability: No items available.
|
|
17.
|
Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor. [electronic resource] by
- Langdon, Casey G
- Platt, James T
- Means, Robert E
- Iyidogan, Pinar
- Mamillapalli, Ramanaiah
- Klein, Michael
- Held, Matthew A
- Lee, Jong Woo
- Koo, Ja Seok
- Hatzis, Christos
- Hochster, Howard S
- Stern, David F
Producer: 20180326
In:
Molecular cancer therapeutics vol. 16
Availability: No items available.
|
|
18.
|
Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care. [electronic resource] by
- Kodack, David P
- Farago, Anna F
- Dastur, Anahita
- Held, Matthew A
- Dardaei, Leila
- Friboulet, Luc
- von Flotow, Friedrich
- Damon, Leah J
- Lee, Dana
- Parks, Melissa
- Dicecca, Richard
- Greenberg, Max
- Kattermann, Krystina E
- Riley, Amanda K
- Fintelmann, Florian J
- Rizzo, Coleen
- Piotrowska, Zofia
- Shaw, Alice T
- Gainor, Justin F
- Sequist, Lecia V
- Niederst, Matthew J
- Engelman, Jeffrey A
- Benes, Cyril H
Producer: 20180723
In:
Cell reports vol. 21
Availability: No items available.
|